| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/02/2000 | WO2000030679A1 Cd25 binding molecules for use in the treatment of manifestations of rejection in transplantation |
| 06/02/2000 | WO2000030678A1 Multivalent t.d. polio vaccine against at least diphtheria, poliomyelitis and tetanus |
| 06/02/2000 | WO2000030673A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 06/02/2000 | WO2000030668A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 06/02/2000 | WO2000030667A2 Compositions and methods using lactadherin or variants thereof |
| 06/02/2000 | WO2000030590A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 06/02/2000 | WO2000030454A1 Compositions and methods using cell fusion |
| 06/02/2000 | WO2000016061A3 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates |
| 06/02/2000 | WO2000015774A9 Useful properties of a bee venom protein and gene encoding same |
| 06/02/2000 | WO2000014244A3 Treatment of cervical cancer |
| 06/02/2000 | WO2000013703A9 Methods of treating hypertension and compositions for use therein |
| 06/02/2000 | WO2000012128A8 Recombinant subunit vaccine against flaviviral infection |
| 06/02/2000 | WO2000007621A3 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 06/02/2000 | WO2000006203A9 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 06/02/2000 | WO1999063095A9 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/02/2000 | WO1999062942A3 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 06/02/2000 | WO1999061097A9 Alpha emitting constructs and uses thereof |
| 06/02/2000 | CA2354152A1 Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications |
| 06/02/2000 | CA2352963A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 06/02/2000 | CA2352617A1 Multivalent t.d. polio vaccine against at least diphtheria, poliomyelitis and tetanus |
| 06/02/2000 | CA2352458A1 Compositions and methods using lactadherin or variants thereof |
| 06/02/2000 | CA2352043A1 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 06/02/2000 | CA2351736A1 Methods of identifying antigen gene sequences |
| 06/02/2000 | CA2351361A1 Gtpase associated proteins |
| 06/02/2000 | CA2351311A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 05/31/2000 | EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 05/31/2000 | EP1004664A1 Compositions and methods using lactadherin or variants thereof |
| 05/31/2000 | EP1004323A1 Method for producing immunoglobulin preparations |
| 05/31/2000 | EP1004314A1 T.d. Polio booster vaccine for a primovaccinated or sensibilisated population |
| 05/31/2000 | EP1004313A1 Cachexia remedy |
| 05/31/2000 | EP1004312A1 Method for treating multiple sclerosis |
| 05/31/2000 | EP1004299A1 Antigen inducers, vaccine precursors, vaccines, antibodies, neutralizing antibodies, antitoxins, idiotypic antibodies, and anti-idiotypic antibodies induced by the idiotypic antibodies |
| 05/31/2000 | EP1003897A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 05/31/2000 | EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 05/31/2000 | EP1003883A1 HISTIDINE KINASE TWO-COMPONENT IN $i(CANDIDA ALBICANS) |
| 05/31/2000 | EP1003879A1 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 05/31/2000 | EP1003878A2 Hiv-1 group o antigens and uses thereof |
| 05/31/2000 | EP1003877A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
| 05/31/2000 | EP1003875A1 Group a streptococcal vaccines |
| 05/31/2000 | EP1003874A1 Neisseria lactoferrin binding protein |
| 05/31/2000 | EP1003862A1 Human longevity-assurance protein homologs |
| 05/31/2000 | EP1003861A2 Mammalian cell membrane proteins; related reagents |
| 05/31/2000 | EP1003859A1 Use of transcription factor brn-3a |
| 05/31/2000 | EP1003856A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 05/31/2000 | EP1003851A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 05/31/2000 | EP1003850A1 Inhibitors of dna immunostimulatory sequence activity |
| 05/31/2000 | EP1003841A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection |
| 05/31/2000 | EP1003787A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 05/31/2000 | EP1003783A2 Lipoprotein-regulating medicaments |
| 05/31/2000 | EP1003780A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 05/31/2000 | EP1003777A1 PGC-1, A NOVEL BROWN FAT PPAR$g(g) COACTIVATOR |
| 05/31/2000 | EP1003773A1 Ctl epitopes from ebv |
| 05/31/2000 | EP1003769A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 05/31/2000 | EP1003763A1 83 human secreted proteins |
| 05/31/2000 | EP1003560A1 Radioprotectant for peptides labeled with radioisotope |
| 05/31/2000 | EP1003552A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/31/2000 | EP1003551A2 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 05/31/2000 | EP1003550A1 Receptor specific transepithelial transport of therapeutics |
| 05/31/2000 | EP1003549A1 IMMUNOGENIC CONJUGATES COMPRISING A GROUP B MENINGOCOCCAL PORIN AND AN $i(H. INFLUENZAE) POLYSACCHARIDE |
| 05/31/2000 | EP1003548A1 A method of inducing a ctl response |
| 05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
| 05/31/2000 | EP1003531A1 Vectors and methods for immunization or therapeutic protocols |
| 05/31/2000 | EP1003507A1 Combination therapy comprising amlodipine and a statin compound |
| 05/31/2000 | EP1003503A1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 05/31/2000 | EP1003478A1 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 05/31/2000 | EP1003379A1 Novel phytase |
| 05/31/2000 | EP0939651B1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia |
| 05/31/2000 | EP0861093B1 Non-invasive Detection of the Integration of a Transgene in Mammals |
| 05/31/2000 | EP0828854B1 Analytical and therapeutic agents |
| 05/31/2000 | EP0690924B1 Anti-microbial agents and screening method therefor |
| 05/31/2000 | EP0635016B1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 05/31/2000 | EP0584082B1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/31/2000 | DE19854749A1 Verwendung von Kapseln, die eine oder mehrere antigene Substanzen enthalten, zur Prävention und/oder Behandlung von Autoimmunerkrankungen The use of capsules which contain one or more antigenic substances, for the prevention and / or treatment of autoimmune diseases |
| 05/31/2000 | CN1255163A Compounds |
| 05/31/2000 | CN1255140A An infections clone for human parainfluenza virus type 3 |
| 05/31/2000 | CN1255135A New class of benzoporphyrin derivative photoactive compounds |
| 05/31/2000 | CN1255067A Use of secretion vector for fertility control by oral vaccination |
| 05/31/2000 | CN1254756A Attenuated virus of ox's viral diarrhea |
| 05/31/2000 | CN1254597A Antiswelling medicine |
| 05/31/2000 | CN1053042C Diagnosis method for the disease with EBV virus in vitro |
| 05/31/2000 | CN1053012C Hog choera virus vaccine and diagnostic |
| 05/30/2000 | US6069242 Mixture of pharmaceutically acceptable carrier and antisense nucleic acid; for diagnosis, imaging, anticarcinogenic agents, antitumor agents |
| 05/30/2000 | US6069236 Desalting, chromatography on anion exchange gel, viral deactivation using solvent-detergent treatment, chromatography on cation exchange gel, recovering; does not cause aggregate-induced complement activation |
| 05/30/2000 | US6069233 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| 05/30/2000 | US6069230 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 05/30/2000 | US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections |
| 05/30/2000 | US6069006 Connective tissue growth factor (CTGF) regulatory nucleic acid sequences |
| 05/30/2000 | US6068992 Production of gonorrheal PI proteins and vaccines |
| 05/30/2000 | US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells |
| 05/30/2000 | US6068973 Suppressing transmission of influenza a virus to cell by contacting cell with influenza virus peptide of specific sequence chosen by a computer algorithm |
| 05/30/2000 | US6068972 Screening by contacting microorganisms with organic solvent, determining expression of acr-like efflux pump gene locus, comparing to control, altered expression indicates activation of multiple antibiotic resistance phenotype |
| 05/30/2000 | US6068842 A polypeptide containing 66 kda protein of borrelia afzelli |
| 05/30/2000 | US6068841 Antibodies to Fas-L for treatment of hepatitis |
| 05/30/2000 | US6068840 Recombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4 |
| 05/30/2000 | US6068829 Relates generally to the fields of molecular medicine and drug delivery and, more specifically, to a method of in vivo panning for identifying a molecule that homes to a specific organ |
| 05/30/2000 | CA2119128C Alleviation of symptoms associated with inflammatory disease states |
| 05/30/2000 | CA2086094C Vaccine compositions containing liposomes |
| 05/30/2000 | CA2063416C Methods of treating or preventing autoimmune uveoretinitis mammals |
| 05/30/2000 | CA2026570C Method for production and purification of hepatitis b vaccine |
| 05/26/2000 | CA2252967A1 Protein fragments for use in protein targeting |